表紙
市場調查報告書

組織銀行的全球市場分析:不同組織 (骨,皮膚,心臟瓣膜,軟組織,角膜,臍帶),不同設備 (凍結保存系統,解凍設備),各用途 (臨床,美容,研究)

Tissue Banking Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 351175
出版日期 內容資訊 英文 112 Pages
商品交期: 2-3個工作天內
價格
組織銀行的全球市場分析:不同組織 (骨,皮膚,心臟瓣膜,軟組織,角膜,臍帶),不同設備 (凍結保存系統,解凍設備),各用途 (臨床,美容,研究) Tissue Banking Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 112 Pages
簡介

藥物研發,臨床實驗,再生醫療,生物銀行的驚異進步,再加上政府及非官方機構的投資擴大,疾病治療的進步等,預測都將推動組織銀行市場的成長與加速發展。組織銀行被視為可望有助於神經疾病,心血管疾病,癌症,糖尿病,其他自體免疫疾病等各種症狀的治療。

本報告提供全球組織銀行市場現狀與今後的市場成長預測,彙整不同組織,設備,各用途趨勢,各地區分析,以及打入市場的主要企業簡介。

第1章 市場概要

第2章 摘要整理

第3章 市場情況

  • 市場佔有率分析
    • 終端用戶分析
    • 專利分析

第4章 市場力量

  • 推動市場的要素
    • 慢性疾病的罹患率上升
    • 生物銀行技術的進步
    • 政府對幹細胞研究的配合和資金
    • 再生醫療的發展
    • 民眾對幹細胞治療的意識擴大
    • 在醫藥品研究開發上活用人體組織
    • 帶動市場成長的策略性合作的擴大
  • 市場課題
    • 組織銀行技術的成本過高
    • 組織穩定性之憂
  • 市場抑制力
    • 生物銀行業務的標準化與調整性
    • 政府的法律規章與給付
    • 複雜的認證政策與嚴苛的許可證法規
  • 該產業的魅力

第5章 策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 市場生命週期分析
  • 供應商及經銷商

第6章 各類型

  • 簡介
  • 血液
  • 皮膚
  • 軟組織
  • 心臟瓣膜
  • 角膜
  • 臍帶

第7章 不同設備

  • 簡介
  • 凍結保存系統
  • 標籤及編碼設備
  • 解凍設備
  • 品管設備
  • 警告·監測設備
  • 其他

第8章 各服務形式

  • 篩檢
  • 組織回收
  • 血清檢驗
  • 微生物檢驗
  • 加工
  • 保存·保管

第9章 各用途

  • 臨床/治療
  • 美容
  • 醫療研究

第10章 各地區分析

  • 南北美洲
  • 歐洲
  • 亞太地區
  • 其他

第11章 市場熵

第12章 企業簡介

第13章 附錄

第14章 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 0014

The global tissue banking market generated revenue of more than $39 billion in 2017 and is projected to rise with a CAGR of 5.62% during 2018-2023. In 2017, the cryopreservation systems in the equipment segmented held the largest share and generated revenue of $2.4 billion and expected to grow with a CAGR of 11.28% during the forecast period. The increased awareness among people about tissue donation, government initiatives and increased healthcare spending will propel the market towards strong growth. Furthermore, Advancement in bio banking technology and evolution in regenerative medicine are anticipated to foster the tissue banking market globally

What is Tissue Banking?

Tissue banking can be defined as a collection of various tissues such as blood, bone, heart valves, skin, cornea, blood vessels, soft tissues and so on from donors, which are further harvested, sterilized, processed and preserved by placing under appropriate storage conditions for use during surgery or medical research. Tissue banking is a novel way to treat several chronic diseases such as blood and immune disorders. Tissue baking also plays an important role in the development of regenerative medicine. Regenerative medicine involves repair and regeneration of cells, tissues and organs disease which are affected by diseases, trauma and aging. For instance, stem cells have the ability to differentiate into specialized type of cells which are used in the treatment of various diseases. Hence, the collection and storage of cord tissue is gaining popularity due its rich source of stem cells.

What are the major applications of Tissue Banking?

Tissue banking has applications such as use of Bone allografts in spinal fusion surgery, tendon allografts for knee ligament replacement, heart valves for treatment of congenital heart defect in children, viable and non-viable skin dressing for patients suffering from burns, powdered bone used in dental repairs, hematopoietic stem cells and marrow used to replace bone marrow. In 2017, Clinical/Therapeutic is the dominant application segment which accounted for nearly 88% of the global tissue banking market revenue and is anticipated to have fastest growth with CAGR of nearly 6% during the forecast period. This high growth is attributed to the growing stem cell banking procedures

Tissue Banking Market

Market Research and Market Trends of Global Tissue Banking Market:

Canadian parliament has announced an investment of $2.5 million for dementia research as more than 400,000 Canadians aged 65 and above is diagnosed with dementia and Alzheimer's. The funding includes 1 million dollars to establish Canadian brain bank network that will be linked to the international Alzheimer's disease Neuroimaging Initiative. The funding will more broadly support brain donation and tissue banking for dementia research programs in Canada which would make way for regenerative and personalized medicine.

Several researches are under progress to better understand the role of mesenchymal stem cells in treating diseases such as Parkinson's, autism and type 1 diabetes. For instance, human umbilical cord tissue-derived mesenchymal stromal cells are being administered every two months in children with Autism to determine the safety of one, two and three intravenous infusions through clinical trials.

The tissue banking market is growing tremendously as several companies are providing various kinds of tissues for research and surgeries. One such company is RegenMed, which is an established company providing musculoskeletal products like bone and connective tissue, or allografts, for use in transplants. Recently it announced that other tissues such as heart valves and skin for burn surgeries will also be processed in and distributed. Thus gaining a wide market in Canada and U.S.

Statline developed StatTrac, a software that captures the donor's information. The API provides real-time access to StatTrac referral data and easy integration of that data into a variety of software systems. This information allows OPOs, tissue banks and eye banks to streamline their processes and make faster decisions within the donation process to save and heal more lives.

Who are the Major Players in Global Tissue Banking market?

The companies referred in the market research report are CCLG Tissue Bank, Taylor-Wharton International LLC, Tecan Group Ltd., BioCision, LLC., Thermo Fisher Scientific Inc., Cureline Inc., Tissue Banks International, Eppendorf AG, Brooks Automation, Inc. and several others.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2023.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Tissue Banking Market - Overview

  • 1.1. Definitions and Scope

2. Tissue Banking Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Tissue Banking Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Tissue Banking Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Tissue Banking Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Tissue Banking Market - By Tissue Type (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Introduction
    • 6.3.2. Blood
    • 6.3.3. Bone
    • 6.3.4. Skin
    • 6.3.5. Soft tissues
    • 6.3.6. Heart valves
    • 6.3.7. Corneas
    • 6.3.8. Umbilical Cord

7. Tissue Banking Market - By Equipment (Market Size -$Million / $Billion)

  • 7.1. Introduction
  • 7.2. Cryopreservation systems
  • 7.3. Labeling and coding equipment
  • 7.4. Thawing equipment
  • 7.5. Quality Control equipment
  • 7.6. Alarming and Monitoring Systems

8. Tissue Banking Market - By Application (Market Size -$Million / $Billion)

  • 8.1. Clinical/Therapeutic
    • 8.1.1. Corneal Transplant
    • 8.1.2. Heart Valve Transplant
    • 8.1.3. Others
  • 8.2. Medical Research
  • 8.3. Cosmetics
    • 8.3.1. Facial Rejuvenation
    • 8.3.2. Breast Enhancement or Enlargement
    • 8.3.3. Nasal Surgery
    • 8.3.4. Others

9. Tissue Banking Market - By Service Type (Market Size -$Million / $Billion)

  • 9.1. Screening
  • 9.2. Tissue Retrieval
  • 9.3. Serological Testing
  • 9.4. Microbial Testing
  • 9.5. Processing
  • 9.6. Storage and Preservation

10. Tissue Banking - By End Use Industry(Market Size -$Million / $Billion)

  • 10.1. Segment type Size and Market Share Analysis
  • 10.2. Application Revenue and Trends by type of Application
  • 10.3. Application Segment Analysis by Type
    • 10.3.1. Hospitals
    • 10.3.2. Tissue Banks
    • 10.3.3. Research and Academic Institutes
    • 10.3.4. Biotech companies
    • 10.3.5. Ambulatory Surgery Centres
    • 10.3.6. Others

11. Tissue Banking - By Geography (Market Size -$Million / $Billion)

  • 11.1. Tissue Banking Market - North America Segment Research
  • 11.2. North America Market Research (Million / $Billion)
    • 11.2.1. Segment type Size and Market Size Analysis
    • 11.2.2. Revenue and Trends
    • 11.2.3. Application Revenue and Trends by type of Application
    • 11.2.4. Company Revenue and Product Analysis
    • 11.2.5. North America Product type and Application Market Size
      • 11.2.5.1. U.S.
      • 11.2.5.2. Canada
      • 11.2.5.3. Mexico
      • 11.2.5.4. Rest of North America
  • 11.3. Tissue Banking - South America Segment Research
  • 11.4. South America Market Research (Market Size -$Million / $Billion)
    • 11.4.1. Segment type Size and Market Size Analysis
    • 11.4.2. Revenue and Trends
    • 11.4.3. Application Revenue and Trends by type of Application
    • 11.4.4. Company Revenue and Product Analysis
    • 11.4.5. South America Product type and Application Market Size
      • 11.4.5.1. Brazil
      • 11.4.5.2. Venezuela
      • 11.4.5.3. Argentina
      • 11.4.5.4. Ecuador
      • 11.4.5.5. Peru
      • 11.4.5.6. Colombia
      • 11.4.5.7. Costa Rica
      • 11.4.5.8. Rest of South America
  • 11.5. Tissue Banking - Europe Segment Research
  • 11.6. Europe Market Research (Market Size -$Million / $Billion)
    • 11.6.1. Segment type Size and Market Size Analysis
    • 11.6.2. Revenue and Trends
    • 11.6.3. Application Revenue and Trends by type of Application
    • 11.6.4. Company Revenue and Product Analysis
    • 11.6.5. Europe Segment Product type and Application Market Size
      • 11.6.5.1. U.K
      • 11.6.5.2. Germany
      • 11.6.5.3. Italy
      • 11.6.5.4. France
      • 11.6.5.5. Netherlands
      • 11.6.5.6. Belgium
      • 11.6.5.7. Spain
      • 11.6.5.8. Denmark
      • 11.6.5.9. Rest of Europe
  • 11.7. Tissue Banking - APAC Segment Research
  • 11.8. APAC Market Research (Market Size -$Million / $Billion)
    • 11.8.1. Segment type Size and Market Size Analysis
    • 11.8.2. Revenue and Trends
    • 11.8.3. Application Revenue and Trends by type of Application
    • 11.8.4. Company Revenue and Product Analysis
    • 11.8.5. APAC Segment - Product type and Application Market Size
      • 11.8.5.1. China
      • 11.8.5.2. Australia
      • 11.8.5.3. Japan
      • 11.8.5.4. South Korea
      • 11.8.5.5. India
      • 11.8.5.6. Taiwan
      • 11.8.5.7. Malaysia

12. Tissue Banking Market - Entropy

  • 12.1. New product launches
  • 12.2. M&A's, collaborations, JVs and partnerships

13. Tissue Banking Market Company Analysis

  • 13.1. Market Share, Company Revenue, Products, M&A, Developments
  • 13.2. CCLG Tissue Bank
  • 13.3. Taylor-Wharton International LLC
  • 13.4. Tecan Group Ltd
  • 13.5. BioCision LLC
  • 13.6. Thermo Fisher Scientific Inc
  • 13.7. Cureline Inc
  • 13.8. Tissue Banks International
  • 13.9. Eppendorf AG
  • 13.10. Brooks Automation Inc
  • 13.11. Company 10
  • 13.12. Company 11
  • 13.13. Company 12 and more

"*Financials would be provided on a best efforts basis for private companies"

14. Tissue Banking Market -Appendix

  • 14.1. Abbreviations
  • 14.2. Sources